A detailed history of Core Cap Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Core Cap Advisors, LLC holds 833 shares of DXCM stock, worth $67,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
833
Holding current value
$67,114
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$64.0 - $116.06 $53,312 - $96,677
833 New
833 $55,000
Q1 2024

Aug 08, 2024

BUY
$114.22 - $140.1 $39,748 - $48,754
348 New
348 $48,000
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $26,173 - $37,782
308 New
308 $34,000
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $16,317 - $31,893
240 New
240 $18,000
Q1 2022

Apr 29, 2022

SELL
$94.08 - $130.2 $158,618 - $219,517
-1,686 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $218,960 - $274,514
1,686 New
1,686 $905,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.